Mason Street Advisors’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-5,301
Closed -$240K 87
2020
Q4
$240K Sell
5,301
-29
-0.5% -$1.31K ﹤0.01% 1380
2020
Q3
$189K Sell
5,330
-2
-0% -$71 ﹤0.01% 1359
2020
Q2
$201K Buy
5,332
+362
+7% +$13.6K ﹤0.01% 1339
2020
Q1
$144K Hold
4,970
﹤0.01% 1347
2019
Q4
$258K Buy
4,970
+290
+6% +$15.1K ﹤0.01% 1328
2019
Q3
$257K Sell
4,680
-62
-1% -$3.41K 0.01% 1303
2019
Q2
$193K Buy
4,742
+178
+4% +$7.25K ﹤0.01% 1369
2019
Q1
$138K Buy
4,564
+151
+3% +$4.57K ﹤0.01% 1478
2018
Q4
$148K Buy
4,413
+92
+2% +$3.09K ﹤0.01% 1395
2018
Q3
$182K Buy
4,321
+63
+1% +$2.65K ﹤0.01% 1399
2018
Q2
$136K Buy
4,258
+182
+4% +$5.81K ﹤0.01% 1450
2018
Q1
$203K Buy
4,076
+263
+7% +$13.1K ﹤0.01% 1337
2017
Q4
$206K Buy
3,813
+101
+3% +$5.46K ﹤0.01% 1328
2017
Q3
$215K Buy
3,712
+98
+3% +$5.68K 0.01% 1300
2017
Q2
$178K Buy
3,614
+191
+6% +$9.41K ﹤0.01% 1324
2017
Q1
$149K Buy
3,423
+228
+7% +$9.93K ﹤0.01% 1351
2016
Q4
$156K Buy
3,195
+153
+5% +$7.47K ﹤0.01% 1325
2016
Q3
$146K Buy
3,042
+240
+9% +$11.5K ﹤0.01% 1302
2016
Q2
$150K Buy
2,802
+255
+10% +$13.7K ﹤0.01% 1260
2016
Q1
$114K Buy
2,547
+188
+8% +$8.42K ﹤0.01% 1300
2015
Q4
$90K Buy
2,359
+203
+9% +$7.75K ﹤0.01% 1337
2015
Q3
$69K Buy
2,156
+136
+7% +$4.35K ﹤0.01% 1371
2015
Q2
$67K Buy
2,020
+48
+2% +$1.59K ﹤0.01% 1397
2015
Q1
$81K Buy
1,972
+106
+6% +$4.35K ﹤0.01% 1351
2014
Q4
$76K Buy
1,866
+58
+3% +$2.36K ﹤0.01% 1765
2014
Q3
$66K Buy
1,808
+322
+22% +$11.8K ﹤0.01% 1772
2014
Q2
$69K Buy
1,486
+108
+8% +$5.02K ﹤0.01% 1761
2014
Q1
$57K Sell
1,378
-425
-24% -$17.6K ﹤0.01% 1774
2013
Q4
$69K Buy
+1,803
New +$69K ﹤0.01% 1775